Personalized circulating tumor DNA (ctDNA) analysis in patients with recurrent/metastatic head & neck squamous cell cancer (R/M HNSCC) | NeoGenomics Laboratories

Publication date

Mon, 06/06/2022 - 12:00

Year

Subtitle

ASCO 2022

File

Personalized_circulating_tumor_DNA_%28ctDNA%29_analysis_in_patients_with_recureent-metastatic_Head_Neck_Squamous_Cell_Cancer_%28R-M_HNSCC%29.pdf (906.19 KB)

Division